The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AEROJET ROCKETDYNE HOLDINGS | COM | 007800105 | 55,820,458 | 1,017,322 | SH | SOLE | 1,017,322 | 0 | 0 | |||
| ALBERTSONS COS INC | COMMON STOCK | 013091103 | 75,858,103 | 3,476,540 | SH | SOLE | 3,476,540 | 0 | 0 | |||
| CRISPR THERAPEUTICS AG | CALL | H17182108 | 1,690,810 | 4,126 | SH | Call | SOLE | 4,126 | 0 | 0 | ||
| DIVERSEY HLDGS LTD | ORD SHS | G28923103 | 23,819,210 | 2,839,000 | SH | SOLE | 2,839,000 | 0 | 0 | |||
| EXELIXIS INC | COM | 30161Q104 | 26,887,770 | 1,407,000 | SH | SOLE | 1,407,000 | 0 | 0 | |||
| FOCUS FINANCIAL PARTNERS | COM CL A | 34417P100 | 91,887,564 | 1,749,906 | SH | SOLE | 1,749,906 | 0 | 0 | |||
| HALLIBURTON CO | PUT | 406216101 | 397,800 | 3,600 | SH | Put | SOLE | 3,600 | 0 | 0 | ||
| HORIZON THERAPEUTICS PLC | SHS | G46188101 | 204,605,470 | 1,989,358 | SH | SOLE | 1,989,358 | 0 | 0 | |||
| NATIONAL INSTRUMENTS CORP | COM | 636518102 | 109,616,780 | 1,909,700 | SH | SOLE | 1,909,700 | 0 | 0 | |||
| PNM RESOURCES INC | COM | 69349H107 | 128,632,506 | 2,852,162 | SH | SOLE | 2,852,162 | 0 | 0 | |||
| QIAGEN NV | CALL | N72482123 | 450,460 | 4,684 | SH | Call | SOLE | 4,684 | 0 | 0 | ||
| SEAGEN INC | COM | 81181C104 | 100,079,200 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | |||
| UNIVAR SOLUTIONS INC | COM | 91336L107 | 32,256,000 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | |||